Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.

BMS-641988 (23) is a novel, nonsteroidal androgen receptor antagonist designed for the treatment of prostate cancer. The compound has high binding affinity for the AR and acts as a functional antagonist in vitro.

BMS-641988 is efficacious in multiple human prostate cancer xenograft models, including CWR22-BMSLD1 where it displays superior efficacy relative to bicalutamide. Based on its promising preclinical profile, BMS-641988 was selected for clinical development.

ACS medicinal chemistry letters 2015 Jun 19*** epublish ***

Aaron Balog, Richard Rampulla, Gregory S Martin, Stanley R Krystek, Ricardo Attar, Janet Dell-John, John D DiMarco, David Fairfax, Jack Gougoutas, Christian L Holst, Andrew Nation, Cheryl Rizzo, Lana M Rossiter, Liang Schweizer, Weifang Shan, Steven Spergel, Thomas Spires, Georgia Cornelius, Marco Gottardis, George Trainor, Gregory D Vite, Mark E Salvati

Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Albany Molecular Research Inc , 21 Corporate Circle, Albany, New York 12203, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Albany Molecular Research Inc , 21 Corporate Circle, Albany, New York 12203, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Albany Molecular Research Inc , 21 Corporate Circle, Albany, New York 12203, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Albany Molecular Research Inc , 21 Corporate Circle, Albany, New York 12203, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States , Bristol Myers-Squibb Research and Development , Princeton, New Jersey 08543, United States

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe